Valproic acid capsule delayed release description: Difference between revisions
Gerald Chi (talk | contribs) Created page with "__NOTOC__ {{Valproic acid}} {{CMG}} ==Title== <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = STAVZOR (VALPROIC ACID) CAPSULE, DELAYED RELEASE ..." |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
== | ==Description== | ||
Valproic acid is a carboxylic acid designated as 2–propylpentanoic acid. It is also known as dipropylacetic acid. Valproic acid (pKa 4.8) has a molecular weight of 144 and occurs as a colorless liquid with a characteristic odor. It is slightly soluble in water (1.3 mg/ml) and very soluble in organic solvents. Valproic acid has the following structure | |||
{| | |||
| [[File:Va17.png|800px|thumb]] | |||
|} | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = STAVZOR (VALPROIC ACID) CAPSULE, DELAYED RELEASE STAVZOR ( VALPROIC ACID) CAPSULE, DELAYED RELEASE [NOVEN THERAPEUTICS, LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=95a4ddd8-b76a-4128-b2ed-8a36cd5738f9 | publisher = | date = | accessdate = }}</ref> | Stavzor (valproic acid) delayed release capsules are for oral administration and are provided as orange-colored, oval-shaped capsules in 3 dosage strengths: 125 mg, 250 mg, 500 mg of valproic acid. | ||
====Inactive Ingredients==== | |||
Stavzor (valproic acid) delayed release capsules also contain ammonia hydroxide, gelatin, glycerin, methacrylic acid copolymer, triethyl citrate, water and FD&C Yellow No. 6 as the colorant. Each capsule is printed with a Opacode WB as the black printing ink.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = STAVZOR (VALPROIC ACID) CAPSULE, DELAYED RELEASE STAVZOR ( VALPROIC ACID) CAPSULE, DELAYED RELEASE [NOVEN THERAPEUTICS, LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=95a4ddd8-b76a-4128-b2ed-8a36cd5738f9 | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
Latest revision as of 23:00, 6 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Description
Valproic acid is a carboxylic acid designated as 2–propylpentanoic acid. It is also known as dipropylacetic acid. Valproic acid (pKa 4.8) has a molecular weight of 144 and occurs as a colorless liquid with a characteristic odor. It is slightly soluble in water (1.3 mg/ml) and very soluble in organic solvents. Valproic acid has the following structure
 |
Stavzor (valproic acid) delayed release capsules are for oral administration and are provided as orange-colored, oval-shaped capsules in 3 dosage strengths: 125 mg, 250 mg, 500 mg of valproic acid.
Inactive Ingredients
Stavzor (valproic acid) delayed release capsules also contain ammonia hydroxide, gelatin, glycerin, methacrylic acid copolymer, triethyl citrate, water and FD&C Yellow No. 6 as the colorant. Each capsule is printed with a Opacode WB as the black printing ink.[1]
References
Adapted from the FDA Package Insert.